NCT04634682View on ClinicalTrials.gov

Effect of MYODM on Quality of Life, Fatigue and Hypersomnia in Patients With Myotonic Dystrophy Type 1

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 9, 2020

Primary Completion Date

November 15, 2021

Study Completion Date

December 3, 2021

Conditions

Myotonic Dystrophy 1

Interventions

DIETARY_SUPPLEMENT

MYODM

Formulated composition containing Theobroma cacao supplemented with caffeine

Trial Locations (1)

20014

Hospital Universitario Donostia, San Sebastián

All Listed Sponsors

lead

Myogem Health Company, S.L.

INDUSTRY

NCT04634682 - Effect of MYODM on Quality of Life, Fatigue and Hypersomnia in Patients With Myotonic Dystrophy Type 1 | Biotech Hunter | Biotech Hunter